Are allopurinol and metabolites found in HPRT deficient erythrocytes responsible for increased NAD synthesis?

Abstract

Aim of this study was to ascertain whether allopurinol, usually administered to hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficient patients, or metabolites abnormally increased in HPRT deficient erythrocytes (NAD, PPribP) could be directly responsible for the reported increased activities of nicotinic acid phosphoribosyltransferase (NAPRT) and… (More)

Topics

  • Presentations referencing similar topics